Skip to main content
Top
Published in: Infection 2/2024

Open Access 08-12-2023 | Streptococci | Brief Report

Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1UK genotype

Authors: Manuel Wolters, Benjamin Berinson, Nicole Degel-Brossmann, Armin Hoffmann, Rico Bluszis, Martin Aepfelbacher, Holger Rohde, Martin Christner

Published in: Infection | Issue 2/2024

Login to get access

Abstract

Purpose

Hypertoxigenic Streptococcus pyogenes emm1 lineage M1UK has recently been associated with upsurges of invasive infections and scarlet fever in several countries, but whole-genome sequencing surveillance data of lineages circulating in Germany is lacking. In this study, we investigated recent iGAS isolates from our laboratory at a German tertiary care center for the presence of the M1UK lineage.

Methods

Whole-genome sequencing was employed to characterize a collection of 47 consecutive non-copy isolates recovered from blood cultures (21) and tissue samples (26) in our laboratory between October 2022 and April 2023.

Results

M protein gene (emm) typing distinguished 14 different emm types, with emm1 (17) being the dominant type. Single-nucleotide polymorphism (SNP) analysis confirmed the presence of all 27 SNPs characteristic for the M1UK lineage in 14 of 17 emm1 isolates.

Conclusion

This study has shown for the first time that M1UK is present in Germany and might constitute a driving force in the observed surge of GAS infections. This observation mirrors developments in the UK and other countries and underscores the importance of WGS surveillance to understand the epidemiology of GAS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, Sriprakash KS, Sanderson-Smith ML, Nizet V. Disease manifestations and pathogenic mechanisms of group A streptococcus. Clin Microbiol Rev. 2014;27:264–301.CrossRefPubMedPubMedCentral Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, Sriprakash KS, Sanderson-Smith ML, Nizet V. Disease manifestations and pathogenic mechanisms of group A streptococcus. Clin Microbiol Rev. 2014;27:264–301.CrossRefPubMedPubMedCentral
2.
go back to reference WHO. Increase in invasive group A streptococcal infections among children in Europe, including fatalities. WHO; 2022. WHO. Increase in invasive group A streptococcal infections among children in Europe, including fatalities. WHO; 2022.
3.
go back to reference van der Putten BCL, Vlaminckx BJM, de Gier B, Freudenburg-de Graaf W, van Sorge NM. Group A streptococcal meningitis with the M1UK variant in the Netherlands. JAMA. 2023;329:1791–2.CrossRefPubMedPubMedCentral van der Putten BCL, Vlaminckx BJM, de Gier B, Freudenburg-de Graaf W, van Sorge NM. Group A streptococcal meningitis with the M1UK variant in the Netherlands. JAMA. 2023;329:1791–2.CrossRefPubMedPubMedCentral
4.
go back to reference Johannesen TB, Munkstrup C, Edslev SM, Baig S, Nielsen S, Funk T, Kristensen DK, Jacobsen LH, Ravn SF, Bindslev N, Gubbels S, Voldstedlund M, Jokelainen P, Hallstrom S, Rasmussen A, Kristinsson KG, Fuglsang-Damgaard D, Dessau RB, Olsen AB, Jensen CS, Skovby A, Ellermann-Eriksen S, Jensen TG, Dzajic E, Ostergaard C, Lomborg Andersen S, Hoffmann S, Andersen PH, Stegger M. Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023. Euro Surveill. 2023. https://doi.org/10.2807/1560-7917.ES.2023.28.26.2300291.CrossRefPubMedPubMedCentral Johannesen TB, Munkstrup C, Edslev SM, Baig S, Nielsen S, Funk T, Kristensen DK, Jacobsen LH, Ravn SF, Bindslev N, Gubbels S, Voldstedlund M, Jokelainen P, Hallstrom S, Rasmussen A, Kristinsson KG, Fuglsang-Damgaard D, Dessau RB, Olsen AB, Jensen CS, Skovby A, Ellermann-Eriksen S, Jensen TG, Dzajic E, Ostergaard C, Lomborg Andersen S, Hoffmann S, Andersen PH, Stegger M. Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023. Euro Surveill. 2023. https://​doi.​org/​10.​2807/​1560-7917.​ES.​2023.​28.​26.​2300291.CrossRefPubMedPubMedCentral
5.
go back to reference Cobo-Vazquez E, Aguilera-Alonso D, Carrasco-Colom J, Calvo C, Saavedra-Lozano J, Ped GASNWG. Increasing incidence and severity of invasive group A streptococcal disease in Spanish children in 2019–2022. Lancet Reg Health Europe. 2023;27: 100597.CrossRefPubMed Cobo-Vazquez E, Aguilera-Alonso D, Carrasco-Colom J, Calvo C, Saavedra-Lozano J, Ped GASNWG. Increasing incidence and severity of invasive group A streptococcal disease in Spanish children in 2019–2022. Lancet Reg Health Europe. 2023;27: 100597.CrossRefPubMed
6.
go back to reference Lassoued Y, Assad Z, Ouldali N, Caseris M, Mariani P, Birgy A, Bonacorsi S, Bidet P, Faye A. Unexpected increase in invasive group A streptococcal infections in children after respiratory viruses outbreak in france: a 15-year time-series analysis. Open Forum Infect Dis. 2023;10:188.CrossRef Lassoued Y, Assad Z, Ouldali N, Caseris M, Mariani P, Birgy A, Bonacorsi S, Bidet P, Faye A. Unexpected increase in invasive group A streptococcal infections in children after respiratory viruses outbreak in france: a 15-year time-series analysis. Open Forum Infect Dis. 2023;10:188.CrossRef
7.
go back to reference Messacar K, Baker RE, Park SW, Nguyen-Tran H, Cataldi JR, Grenfell B. Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption. Lancet. 2022;400:1663–5.CrossRefPubMedPubMedCentral Messacar K, Baker RE, Park SW, Nguyen-Tran H, Cataldi JR, Grenfell B. Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption. Lancet. 2022;400:1663–5.CrossRefPubMedPubMedCentral
8.
go back to reference Davies PJB, Russell CD, Morgan AR, Taori SK, Lindsay D, Ure R, Brown D, Smith A. Increase of severe pulmonary infections in adults caused by M1(UK) Streptococcus pyogenes, Central Scotland UK. Emerg Infect Dis. 2023;29:1638.CrossRefPubMedPubMedCentral Davies PJB, Russell CD, Morgan AR, Taori SK, Lindsay D, Ure R, Brown D, Smith A. Increase of severe pulmonary infections in adults caused by M1(UK) Streptococcus pyogenes, Central Scotland UK. Emerg Infect Dis. 2023;29:1638.CrossRefPubMedPubMedCentral
9.
go back to reference Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, Pearson M, Asai M, Lobkowicz L, Chow JY, Parkhill J, Lamagni T, Chalker VJ, Sriskandan S. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis. 2019;19:1209–18.CrossRefPubMedPubMedCentral Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, Pearson M, Asai M, Lobkowicz L, Chow JY, Parkhill J, Lamagni T, Chalker VJ, Sriskandan S. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis. 2019;19:1209–18.CrossRefPubMedPubMedCentral
10.
go back to reference Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW, Kristinsson KG, Gottfredsson M, Vuopio J, Raisanen K, Caugant DA, Steinbakk M, Low DE, McGeer A, Darenberg J, Henriques-Normark B, Van Beneden CA, Hoffmann S, Musser JM. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci USA. 2014;111:E1768-1776.CrossRefPubMedPubMedCentral Nasser W, Beres SB, Olsen RJ, Dean MA, Rice KA, Long SW, Kristinsson KG, Gottfredsson M, Vuopio J, Raisanen K, Caugant DA, Steinbakk M, Low DE, McGeer A, Darenberg J, Henriques-Normark B, Van Beneden CA, Hoffmann S, Musser JM. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci USA. 2014;111:E1768-1776.CrossRefPubMedPubMedCentral
11.
go back to reference Davies MR, Keller N, Brouwer S, Jespersen MG, Cork AJ, Hayes AJ, Pitt ME, De Oliveira DMP, Harbison-Price N, Bertolla OM, Mediati DG, Curren BF, Taiaroa G, Lacey JA, Smith HV, Fang NX, Coin LJM, Stevens K, Tong SYC, Sanderson-Smith M, Tree JJ, Irwin AD, Grimwood K, Howden BP, Jennison AV, Walker MJ. Detection of Streptococcus pyogenes M1(UK) in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA. Nat Commun. 2023;14:1051.ADSCrossRefPubMedPubMedCentral Davies MR, Keller N, Brouwer S, Jespersen MG, Cork AJ, Hayes AJ, Pitt ME, De Oliveira DMP, Harbison-Price N, Bertolla OM, Mediati DG, Curren BF, Taiaroa G, Lacey JA, Smith HV, Fang NX, Coin LJM, Stevens K, Tong SYC, Sanderson-Smith M, Tree JJ, Irwin AD, Grimwood K, Howden BP, Jennison AV, Walker MJ. Detection of Streptococcus pyogenes M1(UK) in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA. Nat Commun. 2023;14:1051.ADSCrossRefPubMedPubMedCentral
12.
go back to reference Rumke LW, de Gier B, Vestjens SMT, van der Ende A, van Sorge NM, Vlaminckx BJM, Witteveen S, van Santen M, Schouls LM, Kuijper EJ. Dominance of M1(UK) clade among Dutch M1 Streptococcus pyogenes. Lancet Infect Dis. 2020;20:539–40.CrossRefPubMed Rumke LW, de Gier B, Vestjens SMT, van der Ende A, van Sorge NM, Vlaminckx BJM, Witteveen S, van Santen M, Schouls LM, Kuijper EJ. Dominance of M1(UK) clade among Dutch M1 Streptococcus pyogenes. Lancet Infect Dis. 2020;20:539–40.CrossRefPubMed
13.
go back to reference Li Y, Nanduri SA, Van Beneden CA, Beall BW. M1(UK) lineage in invasive group A streptococcus isolates from the USA. Lancet Infect Dis. 2020;20:538–9.CrossRefPubMedPubMedCentral Li Y, Nanduri SA, Van Beneden CA, Beall BW. M1(UK) lineage in invasive group A streptococcus isolates from the USA. Lancet Infect Dis. 2020;20:538–9.CrossRefPubMedPubMedCentral
14.
go back to reference Demczuk W, Martin I, Domingo FR, MacDonald D, Mulvey MR. Identification of Streptococcus pyogenes M1(UK) clone in Canada. Lancet Infect Dis. 2019;19:1284–5.CrossRefPubMed Demczuk W, Martin I, Domingo FR, MacDonald D, Mulvey MR. Identification of Streptococcus pyogenes M1(UK) clone in Canada. Lancet Infect Dis. 2019;19:1284–5.CrossRefPubMed
15.
go back to reference Li Y, Rivers J, Mathis S, Li Z, Chochua S, Metcalf BJ, Beall B, Onukwube J, Gregory CJ, McGee L. Expansion of invasive group A streptococcus M1(UK) lineage in active bacterial core surveillance, United States, 2019–2021. Emerg Infect Dis. 2023;29:2116–20.CrossRefPubMed Li Y, Rivers J, Mathis S, Li Z, Chochua S, Metcalf BJ, Beall B, Onukwube J, Gregory CJ, McGee L. Expansion of invasive group A streptococcus M1(UK) lineage in active bacterial core surveillance, United States, 2019–2021. Emerg Infect Dis. 2023;29:2116–20.CrossRefPubMed
16.
go back to reference Rodriguez-Ruiz JP, Lin Q, Lammens C, Smeesters PR, van Kleef-van Koeveringe S, Matheeussen V, Malhotra-Kumar S. Increase in bloodstream infections caused by emm1 group A streptococcus correlates with emergence of toxigenic M1(UK), Belgium, May 2022 to August 2023. Euro Surveill. 2023;28:2300422.CrossRefPubMedPubMedCentral Rodriguez-Ruiz JP, Lin Q, Lammens C, Smeesters PR, van Kleef-van Koeveringe S, Matheeussen V, Malhotra-Kumar S. Increase in bloodstream infections caused by emm1 group A streptococcus correlates with emergence of toxigenic M1(UK), Belgium, May 2022 to August 2023. Euro Surveill. 2023;28:2300422.CrossRefPubMedPubMedCentral
17.
go back to reference Gouveia C, Bajanca-Lavado MP, Mamede R, Araujo Carvalho A, Rodrigues F, Melo-Cristino J, Ramirez M, Friaes A, Portuguese Study Group of Pediatric Invasive Streptococcal, D., and Portuguese Study Group of Paediatric Invasive Streptococcal, D. Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1(UK) and diverse emm12 isolates, Portugal, September 2022 to May 2023. Euro Surveill. 2023;28:2300427.CrossRefPubMedPubMedCentral Gouveia C, Bajanca-Lavado MP, Mamede R, Araujo Carvalho A, Rodrigues F, Melo-Cristino J, Ramirez M, Friaes A, Portuguese Study Group of Pediatric Invasive Streptococcal, D., and Portuguese Study Group of Paediatric Invasive Streptococcal, D. Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1(UK) and diverse emm12 isolates, Portugal, September 2022 to May 2023. Euro Surveill. 2023;28:2300427.CrossRefPubMedPubMedCentral
19.
20.
go back to reference Prjibelski A, Antipov D, Meleshko D, Lapidus A, Korobeynikov A. Using SPAdes De Novo assembler. Curr Protoc Bioinform. 2020;70: e102.CrossRef Prjibelski A, Antipov D, Meleshko D, Lapidus A, Korobeynikov A. Using SPAdes De Novo assembler. Curr Protoc Bioinform. 2020;70: e102.CrossRef
22.
go back to reference Feldgarden M, Brover V, Gonzalez-Escalona N, Frye JG, Haendiges J, Haft DH, Hoffmann M, Pettengill JB, Prasad AB, Tillman GE, Tyson GH, Klimke W. AMRFinderPlus and the reference gene catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci Rep. 2021;11:12728.ADSCrossRefPubMedPubMedCentral Feldgarden M, Brover V, Gonzalez-Escalona N, Frye JG, Haendiges J, Haft DH, Hoffmann M, Pettengill JB, Prasad AB, Tillman GE, Tyson GH, Klimke W. AMRFinderPlus and the reference gene catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci Rep. 2021;11:12728.ADSCrossRefPubMedPubMedCentral
23.
go back to reference Chen L, Zheng D, Liu B, Yang J, Jin Q. VFDB 2016: hierarchical and refined dataset for big data analysis–10 years on. Nucleic Acids Res. 2016;44:D694-697.CrossRefPubMed Chen L, Zheng D, Liu B, Yang J, Jin Q. VFDB 2016: hierarchical and refined dataset for big data analysis–10 years on. Nucleic Acids Res. 2016;44:D694-697.CrossRefPubMed
25.
go back to reference Friaes A, Mamede R, Ferreira M, Melo-Cristino J, Ramirez M. Annotated whole-genome multilocus sequence typing schema for scalable high-resolution typing of Streptococcus pyogenes. J Clin Microbiol. 2022;60: e0031522.CrossRefPubMed Friaes A, Mamede R, Ferreira M, Melo-Cristino J, Ramirez M. Annotated whole-genome multilocus sequence typing schema for scalable high-resolution typing of Streptococcus pyogenes. J Clin Microbiol. 2022;60: e0031522.CrossRefPubMed
26.
go back to reference Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, Parkhill J, Harris SR. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43: e15.CrossRefPubMed Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, Parkhill J, Harris SR. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43: e15.CrossRefPubMed
27.
go back to reference Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, Lanfear R. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37:1530–4.CrossRefPubMedPubMedCentral Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, Lanfear R. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37:1530–4.CrossRefPubMedPubMedCentral
Metadata
Title
Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1UK genotype
Authors
Manuel Wolters
Benjamin Berinson
Nicole Degel-Brossmann
Armin Hoffmann
Rico Bluszis
Martin Aepfelbacher
Holger Rohde
Martin Christner
Publication date
08-12-2023
Publisher
Springer Berlin Heidelberg
Keyword
Streptococci
Published in
Infection / Issue 2/2024
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-023-02137-1

Other articles of this Issue 2/2024

Infection 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.